TipRanks
Go Ultimate55% OFF

CBAK Energy Technology (BD5) AI Stock Analysis

6 Followers
DE:BD5

CBAK Energy Technology

(Frankfurt:BD5)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recent Cash GenerationStrong recent operating and free cash flow provides internal funding for production, product development, and working-capital needs. If maintained, this reduces reliance on external financing and gives CBAK greater flexibility to support battery-market growth despite reported earnings volatility.
Negative Factors
Unstable ProfitabilityThe shift from positive profitability to material losses, followed by continued slightly negative TTM margins, weakens confidence that revenue converts reliably into earnings. Persistent margin instability can constrain reinvestment, reduce financial resilience, and make future shareholder returns less predictable.

CBAK Energy Technology (BD5) vs. iShares MSCI Germany ETF (EWG)

-40%-30%-20%-10%0%10%20%DE:BD5-31.41%EWG+5.34%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 97.51M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-5.9
Beta (1Y)
0.78
Revenue Growth
39.38%
EPS Growth
-5432.26%
Country
Germany
Employees
1,739
Sector
Industrials
Sector Strength
63
Industry
Electrical Equipment & Parts

CBAK Energy Technology Business Overview & Revenue Model

Company Description

CBAK Energy Technology, Inc. engages in the manufacture, commercialization, and distribution of lithium-ion rechargeable batteries. Its products are used for electronic vehicles, light electric vehicles, electric tools, energy storage, uninterruptibl...

CBAK Energy Technology Earnings Call Summary

Earnings Call Date:Mar 29, 2026(Q4-2025)|% Change Since:-22.46%|Next Earnings Date:May 18, 2022
Earnings Call SentimentPositive

The call conveyed strong top-line momentum, a robust turnaround in the raw materials segment (Hitrans), meaningful cash generation, major capacity additions and expanding global commercial partnerships — all signaling growth potential. Offsetting these positives were substantial margin compression, reported operating and net losses for both the quarter and full year, and timing risks as new production lines ramp. Management frames the losses as temporary, driven by strategic investments and capacity transitions that should unlock larger scale and improved margins in 2026–2027.

Positive Updates

Quarterly Revenue Surge
Consolidated net revenue for Q4 2025 rose 131.8% year-over-year to $58.80 million, demonstrating strong near-term top-line momentum.

Negative Updates

Significant Margin Compression
Q4 gross profit was $4.28 million with a gross margin of 7.3% (down from 13.1% in Q4 2024). Full-year gross profit was $18.42 million with a 9.4% margin (down from 23.7% in 2024), driven by higher unit costs, suboptimal yields and fixed-cost absorption during capacity ramp-ups.

Company Guidance

Management guided that consolidated sales should hit a record high in 2026 as new capacity ramps complete — the Dalian 40135 line (2.3 GWh commissioned end‑2025) is in intensive ramp with demand > supply and is expected to finish ramping in H1 2026, while Nanjing added two Phase II lines (+3.0 GWh to complement 1.5 GWh Phase I) targeted to reach full capacity in early 2027 (management hopes H2 2026 if possible). They expect gross margins, which compressed to 7.3% in Q4 and 9.4% for FY2025 (vs. 13.1% and 23.7% prior year), to gradually recover in 2H 2026 and improve for full‑year 2026 as yields and fixed‑cost absorption normalize. Management pointed to Hitrans’ momentum (FY revenue $89.21M, +123% YoY) and planned capacity additions — a 10,000 MT cathode plant and 37,000 MT precursor facility with the cathode plant slated for full operation in H1 2027 — as additional upside, reiterated balance sheet strength ($75.68M cash, $48.55M net cash from operations, $44.65M capex spent in 2025), noted R&D of $15.8M (up 21%) to accelerate large‑format and sodium‑ion programs, and flagged export tax rebate cuts (13%→9%→6%→0% by Jan 2027) as a driver of their Malaysia localization plan (subsidiary incorporated Apr 30, 2025).

CBAK Energy Technology Risk Analysis

CBAK Energy Technology disclosed 114 risk factors in its most recent earnings report. CBAK Energy Technology reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

CBAK Energy Technology Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:BD5 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
ESPESP84Outperform$158.03M12.8420.22%3.37%4.95%28.35%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
RFILRFIL63Neutral$83.58M34.526.69%―13.04%―
ULBIULBI57Neutral$260.28M-39.03-4.95%―4.69%-304.68%
FLUXFLUX43Neutral$9.81M-1.16-261.63%―-36.58%5.31%
DFLIDFLI40Underperform$3.41M-0.01-1565.55%―-4.85%53.62%

* Industrials Sector Average

Performance Comparison

-100%0%100%DE:BD5ESPRFILULBIFLUXDFLIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:BD5 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:BD5Cbak Energy Tech0.54-0.22-29.61%
ESPEspey Mfg. & Electronics51.8615.6343.13%
RFILRf Industries, Ltd.7.680.162.13%
ULBIUltralife15.638.62122.97%
FLUXFlux Power Holdings0.45-1.94-81.34%
DFLIDragonfly Energy Holdings Corp2.00-85.20-97.71%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.